🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of uncertain source.

Several professionals said the demand for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Removal

According to the social media company, the platform has removed problematic content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of slimming results, glowing testimonials and detailed instructions for mixing or injecting at residence.

After moments of joining one group, a seller shared contact information, where most purchases take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Information and Costs

Within these groups, posts show dark colored packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly serious health risks”.